Latest Articles

Publication Date
Beneficial Effects of Fisetin, a Senotherapeutic Compound, in Women's Reproductive Health and Diseases: Evidence from In Vitro to Clinical Studies.

Fisetin is a naturally occurring flavonoid, a type of polyphenol found in fruits and vegetables such as strawberries, apples, persimmons, and onions. It has gained increasing attention for its antioxidant …

Published: Jan. 25, 2026, midnight
Optimal Laparoscopic Surgical Technique for Preserving Fertility and Ovarian Reserve in Patients with Endometrioma: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials.

This systematic review and Bayesian network meta-analysis aimed to evaluate the comparative efficacy and safety of various laparoscopic techniques for endometrioma management, focusing on their impact on fertility outcomes and …

Published: Jan. 24, 2026, midnight
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - targetedonc.com

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer targetedonc.com

Published: Jan. 22, 2026, 4:02 p.m.
First they Came for our AHRQ Articles, then they Came for AHRQ: Scientific Suppression and Struggle in the United States.

The authors of this commentary published two peer-reviewed online articles in 2020 and 2022 on the U.S. Agency for Healthcare Research and Quality (AHRQ) PSNet that were removed by the …

Published: Jan. 21, 2026, midnight
In silico evaluation of procyanidin as a potential ESR1 inhibitor: docking and MD insights in uterine fibroids and endometriosis.

These are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age diseases. The existing treatments, such as hormonal drugs and selective estrogen receptor …

Published: Jan. 14, 2026, midnight
Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective.

Tea, among the most widely consumed beverages worldwide, is rich in polyphenolic compounds known as catechins, particularly epigallocatechin gallate (EGCG). This review aims to synthesize recent findings and ongoing controversies …

Published: Jan. 13, 2026, midnight
Risk of postpartum depression among women with endometriosis: the Norwegian mother, father and child cohort study (MoBa).

Women with endometriosis have a higher burden of anxiety and depression. Whether they are at increased risk of postpartum depression (PPD) remains unclear. We aimed to compare the risk of …

Published: Jan. 12, 2026, midnight
En Bloc Hysterectomy with segmental bowel resection by NOSE-procedure: Surgical Management of Ovarian Cancer in context of Deep Infiltrating Endometriosis.

To show the safety of en bloc hysterectomy with segmental bowel resection utilizing the NOSE-technique in the management of ovarian cancer and deep infiltrating endometriosis (DIE).

Published: Jan. 12, 2026, midnight
Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024.

Spironolactone, eplerenone, and finerenone are three commonly used mineralocorticoid receptor antagonists (MRAs) with cardioprotective and renoprotective effects. However, comparative real-world safety evaluations remain limited. This study aimed to assess and …

Published: Jan. 7, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!